🚨 $LNTH
Heino Mary Anne (Executive Chair and CEO) reported special transactions (Non-P/S).
Heino Mary Anne (Executive Chair and CEO) reported special transactions (Non-P/S).
SEC Filing: LNTH
Click to view the official SEC document.
www.sec.gov
June 3, 2026 at 11:16 PM
🚨 $LNTH
Heino Mary Anne (Executive Chair and CEO) reported special transactions (Non-P/S).
Heino Mary Anne (Executive Chair and CEO) reported special transactions (Non-P/S).
🚨 $LNTH
As previously disclosed, on August 3, 2026, Lantheus Holdings, Inc., a Delaware corporation , entered into an Agreement and Plan of Merger by and among the Company, Curium US Holdings LLC, a Delaware limited liability company , and Coco Merger Sub Inc., a Delaware corporation and a wholly...
As previously disclosed, on August 3, 2026, Lantheus Holdings, Inc., a Delaware corporation , entered into an Agreement and Plan of Merger by and among the Company, Curium US Holdings LLC, a Delaware limited liability company , and Coco Merger Sub Inc., a Delaware corporation and a wholly...
SEC Filing: LNTH
Click to view the official SEC document.
www.sec.gov
September 21, 2026 at 8:08 PM
🚨 $LNTH
As previously disclosed, on August 3, 2026, Lantheus Holdings, Inc., a Delaware corporation , entered into an Agreement and Plan of Merger by and among the Company, Curium US Holdings LLC, a Delaware limited liability company , and Coco Merger Sub Inc., a Delaware corporation and a wholly...
As previously disclosed, on August 3, 2026, Lantheus Holdings, Inc., a Delaware corporation , entered into an Agreement and Plan of Merger by and among the Company, Curium US Holdings LLC, a Delaware limited liability company , and Coco Merger Sub Inc., a Delaware corporation and a wholly...
BUY $LNTH (LNTH.O) [FDA] @ 12:00:06Z
September 22, 2026 at 12:00 PM
BUY $LNTH (LNTH.O) [FDA] @ 12:00:06Z
#gAI They began life as Ezra and Cash in Cross At Dawn. I've disagreed with channel creator publicly + privately that AI "actors" are a thing like RL stars who call it career progression to take on new roles.
I may be wrong here with this new storyline.
(21:54) www.youtube.com/watch?v=LNth...
I may be wrong here with this new storyline.
(21:54) www.youtube.com/watch?v=LNth...
He Threatened to Expose Their SecretBut It Got Him Promoted | The Clear Current Part 1 | BL Movie 4K
YouTube video by PureWild
www.youtube.com
September 23, 2026 at 11:56 PM
#gAI They began life as Ezra and Cash in Cross At Dawn. I've disagreed with channel creator publicly + privately that AI "actors" are a thing like RL stars who call it career progression to take on new roles.
I may be wrong here with this new storyline.
(21:54) www.youtube.com/watch?v=LNth...
I may be wrong here with this new storyline.
(21:54) www.youtube.com/watch?v=LNth...
David Shulman, MD, Director of the Dana-Farber AYA Sarcoma Program, discusses a newly opened phase 1/2 trial of LNTH-2403, an LRRC15-targeted radiopharmaceutical, for relapsed/refractory osteosarcoma. @danafarber.bsky.social @danafarbernews.bsky.social
www.youtube.com/watch?v=vQ1a...
www.youtube.com/watch?v=vQ1a...
OsteoBites | Phase 1/2 Study of LNTH 2403 for Relapsed Osteosarcoma
YouTube video by Osteosarcoma: MIB Agents Osteosarcoma Alliance
www.youtube.com
June 29, 2026 at 2:00 PM
David Shulman, MD, Director of the Dana-Farber AYA Sarcoma Program, discusses a newly opened phase 1/2 trial of LNTH-2403, an LRRC15-targeted radiopharmaceutical, for relapsed/refractory osteosarcoma. @danafarber.bsky.social @danafarbernews.bsky.social
www.youtube.com/watch?v=vQ1a...
www.youtube.com/watch?v=vQ1a...
Accrochez vos ceintures, avec Khatia Buniatishvili on perd 15 secondes encore, c'est plus rapide, mais moins sec, mais plus nerveux, ça me fout des palpitations, je sais pas si j'aime bien, mais disons que c'est un parti-pris qui fait relire le texte www.youtube.com/watch?v=LNth...
Lied ohne Worte in F-Sharp Minor, Op. 67/2
YouTube video by Khatia Buniatishvili - Topic
www.youtube.com
October 11, 2025 at 9:19 PM
Accrochez vos ceintures, avec Khatia Buniatishvili on perd 15 secondes encore, c'est plus rapide, mais moins sec, mais plus nerveux, ça me fout des palpitations, je sais pas si j'aime bien, mais disons que c'est un parti-pris qui fait relire le texte www.youtube.com/watch?v=LNth...
Lantheus Holdings (LNTH) Shares Increase on Sale Exploration Report
Lantheus Holdings (LNTH) shares saw a notable increase following reports that the company is exploring a potential s…
https://newsstocks.live/news/lantheus-holdings-lnth-shares-increase-on-sale-exploration-report #Finance #Markets
Lantheus Holdings (LNTH) shares saw a notable increase following reports that the company is exploring a potential s…
https://newsstocks.live/news/lantheus-holdings-lnth-shares-increase-on-sale-exploration-report #Finance #Markets
May 22, 2026 at 8:02 PM
Lantheus Holdings (LNTH) Shares Increase on Sale Exploration Report
Lantheus Holdings (LNTH) shares saw a notable increase following reports that the company is exploring a potential s…
https://newsstocks.live/news/lantheus-holdings-lnth-shares-increase-on-sale-exploration-report #Finance #Markets
Lantheus Holdings (LNTH) shares saw a notable increase following reports that the company is exploring a potential s…
https://newsstocks.live/news/lantheus-holdings-lnth-shares-increase-on-sale-exploration-report #Finance #Markets
@lantheus.bsky.social closes SPECT business sale to SHINE Technologies
*Includes Technelite, Neurolite, Xenon Gas & Cardiolite
$LNTH
finance.yahoo.com/news/lantheu...
*Includes Technelite, Neurolite, Xenon Gas & Cardiolite
$LNTH
finance.yahoo.com/news/lantheu...
Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies
BEDFORD, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians ...
finance.yahoo.com
January 2, 2026 at 2:13 PM
@lantheus.bsky.social closes SPECT business sale to SHINE Technologies
*Includes Technelite, Neurolite, Xenon Gas & Cardiolite
$LNTH
finance.yahoo.com/news/lantheu...
*Includes Technelite, Neurolite, Xenon Gas & Cardiolite
$LNTH
finance.yahoo.com/news/lantheu...
Curium is in advanced talks to buy #$LNTH for ~$7B ($102/share + $12.50 CVRs). Announcement possible soon; no final deal confirmed yet. notreload.xyz/xy/curium-ne...
Curium Nears $7 Billion Acquisition of Lantheus Holdings
Curium is in advanced talks to buy Lantheus for ~$7B ($102/share + $12.50 CVRs). Announcement possible soon; no final deal confirmed yet.
notreload.xyz
July 28, 2026 at 10:22 AM
Curium is in advanced talks to buy #$LNTH for ~$7B ($102/share + $12.50 CVRs). Announcement possible soon; no final deal confirmed yet. notreload.xyz/xy/curium-ne...
Breaking News: ( NASDAQ: #LNTH ) Lantheus Applauds CMS' CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care
#StockMarket #News
#StockMarket #News
November 4, 2024 at 8:25 PM
Telix Pharmaceuticals announced Sunday it will acquire private German radioisotope company ITM Isotope Technologies Munich for $1.65 billion upfront plus up to $700 million in…
$TLX $NVS $LNTH named in the read, sent 8:56:59 AM ET. One of 23 alerts today.
knowfir.st
$TLX $NVS $LNTH named in the read, sent 8:56:59 AM ET. One of 23 alerts today.
knowfir.st
September 21, 2026 at 2:59 PM
Telix Pharmaceuticals announced Sunday it will acquire private German radioisotope company ITM Isotope Technologies Munich for $1.65 billion upfront plus up to $700 million in…
$TLX $NVS $LNTH named in the read, sent 8:56:59 AM ET. One of 23 alerts today.
knowfir.st
$TLX $NVS $LNTH named in the read, sent 8:56:59 AM ET. One of 23 alerts today.
knowfir.st
Lantheus reports 3Q
*Revs of $384mm vs our $361mm
*adj EPS of $1.27 vs our $1.16
*CEO to retire
*Call @ 8 am ET
$LNTH
lantheusholdings.gcs-web.com/news-release...
*Revs of $384mm vs our $361mm
*adj EPS of $1.27 vs our $1.16
*CEO to retire
*Call @ 8 am ET
$LNTH
lantheusholdings.gcs-web.com/news-release...
lantheusholdings.gcs-web.com
November 6, 2025 at 12:11 PM
Lantheus reports 3Q
*Revs of $384mm vs our $361mm
*adj EPS of $1.27 vs our $1.16
*CEO to retire
*Call @ 8 am ET
$LNTH
lantheusholdings.gcs-web.com/news-release...
*Revs of $384mm vs our $361mm
*adj EPS of $1.27 vs our $1.16
*CEO to retire
*Call @ 8 am ET
$LNTH
lantheusholdings.gcs-web.com/news-release...
#LNTH Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
https://www.stocktitan.net/news/LNTH/lantheus-announces-fda-approval-of-pylarify-tru-vu-tm-piflufolastat-w5irha224hip.html
https://www.stocktitan.net/news/LNTH/lantheus-announces-fda-approval-of-pylarify-tru-vu-tm-piflufolastat-w5irha224hip.html
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
Lantheus (NASDAQ: LNTH) announced FDA approval of PYLARIFY TruVu (piflufolastat F 18), a new formulation of its PSMA PET imaging agent designed for larger batch production and broader patient access. The product, approved via the 505(b)(2) pathway relying on OSPREY and CONDOR data, is expected to launch in 4Q 2026 with a phased geographic rollout. More than 760,000 patients have received PSMA PET scans with PYLARIFY since May 2021. TruVu aims to improve stability at higher radioactive concentrations to enable larger batches and wider distribution.
www.stocktitan.net
March 6, 2026 at 9:01 PM
#LNTH Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
https://www.stocktitan.net/news/LNTH/lantheus-announces-fda-approval-of-pylarify-tru-vu-tm-piflufolastat-w5irha224hip.html
https://www.stocktitan.net/news/LNTH/lantheus-announces-fda-approval-of-pylarify-tru-vu-tm-piflufolastat-w5irha224hip.html
📈 Investors are snapping up the stocks joining the Nasdaq 100 next week!
#PLTR +0.9%
#MSTR +5.8%
#AXON +2.8%
#StockMarket #Nasdaq100 #SPY #QQQ #TSLA #NVDA #AMZN #NFLX #MSFT #AAPL #META #GOOG #PYPL #LULU #DIS #AMD #COIN #SHOP #ACHR #UNH #RKLB #HOOD #MARA #SMCI #RBLX #LNTH #TEAM #SOFI
#PLTR +0.9%
#MSTR +5.8%
#AXON +2.8%
#StockMarket #Nasdaq100 #SPY #QQQ #TSLA #NVDA #AMZN #NFLX #MSFT #AAPL #META #GOOG #PYPL #LULU #DIS #AMD #COIN #SHOP #ACHR #UNH #RKLB #HOOD #MARA #SMCI #RBLX #LNTH #TEAM #SOFI
December 16, 2024 at 12:10 PM
Stage Analysis Screener – Stage 2 Breakout Attempts
LNTH, VZ, JKHY, AWK, OTIS, EXPD, ECX, AMT, O, SVM, STE, VOD, RKT, SQM, WU, GSK, MYE
Filters:
Stage: 2A, 2
Stage Change: Stage Changed
Market Cap: +Mini (over $300mln)
Average Volume: Over 1.5M
Relative Volume: >= 1
stageanalysis.net
LNTH, VZ, JKHY, AWK, OTIS, EXPD, ECX, AMT, O, SVM, STE, VOD, RKT, SQM, WU, GSK, MYE
Filters:
Stage: 2A, 2
Stage Change: Stage Changed
Market Cap: +Mini (over $300mln)
Average Volume: Over 1.5M
Relative Volume: >= 1
stageanalysis.net
March 8, 2025 at 2:04 AM
Stage Analysis Screener – Stage 2 Breakout Attempts
LNTH, VZ, JKHY, AWK, OTIS, EXPD, ECX, AMT, O, SVM, STE, VOD, RKT, SQM, WU, GSK, MYE
Filters:
Stage: 2A, 2
Stage Change: Stage Changed
Market Cap: +Mini (over $300mln)
Average Volume: Over 1.5M
Relative Volume: >= 1
stageanalysis.net
LNTH, VZ, JKHY, AWK, OTIS, EXPD, ECX, AMT, O, SVM, STE, VOD, RKT, SQM, WU, GSK, MYE
Filters:
Stage: 2A, 2
Stage Change: Stage Changed
Market Cap: +Mini (over $300mln)
Average Volume: Over 1.5M
Relative Volume: >= 1
stageanalysis.net
$LNTH +2.9% [Lantheus licenses PYLARIFY, a leading PSMA PET imaging agent for prostate cancer, exclusively to GE HealthCare for development, manufacturing, and sales in Japan, a key international market.] notreload.xyz/lantheus-lic...
Lantheus Licenses PYLARIFY to GE HealthCare for Japan
Lantheus licenses PYLARIFY, a leading PSMA PET imaging agent for prostate cancer, exclusively to GE HealthCare for development, manufacturing, and sales in Japan, a key international market.
notreload.xyz
September 24, 2025 at 6:30 PM
$LNTH +2.9% [Lantheus licenses PYLARIFY, a leading PSMA PET imaging agent for prostate cancer, exclusively to GE HealthCare for development, manufacturing, and sales in Japan, a key international market.] notreload.xyz/lantheus-lic...
$LNTH Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market
www.globenewswire.com/news-release...
www.globenewswire.com/news-release...
Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market
Enhances Lantheus’ growth profile with Neuraceq®, a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in patients evaluated for...
www.globenewswire.com
January 13, 2025 at 5:18 AM
$LNTH Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market
www.globenewswire.com/news-release...
www.globenewswire.com/news-release...
#$LNTH / Curium have to file HSR by today.
Not a clearance deadline. A filing deadline — written into the merger agreement so one side can't stall the clock by sitting on the paperwork.
Boring covenant. It's also why deals with motivated buyers close faster than deals without.
Not a clearance deadline. A filing deadline — written into the merger agreement so one side can't stall the clock by sitting on the paperwork.
Boring covenant. It's also why deals with motivated buyers close faster than deals without.
September 17, 2026 at 11:40 AM
#$LNTH / Curium have to file HSR by today.
Not a clearance deadline. A filing deadline — written into the merger agreement so one side can't stall the clock by sitting on the paperwork.
Boring covenant. It's also why deals with motivated buyers close faster than deals without.
Not a clearance deadline. A filing deadline — written into the merger agreement so one side can't stall the clock by sitting on the paperwork.
Boring covenant. It's also why deals with motivated buyers close faster than deals without.
Investigating Shareholder Rights: Are LNTH, ITGR, and CZR Ensuring Fair Value for Investors?#USA#New_York#Lantheus#Caesars#Integer
Investigating Shareholder Rights: Are LNTH, ITGR, and CZR Ensuring Fair Value for Investors?
This article examines if companies LNTH, ITGR, and CZR are offering fair deals to their shareholders amidst legal scrutiny.
third-news.com
September 11, 2026 at 4:34 PM
🚨 $LNTH
Dinkelborg Ludger (See Remarks) reported special transactions (Non-P/S).
Dinkelborg Ludger (See Remarks) reported special transactions (Non-P/S).
SEC Filing: LNTH
Click to view the official SEC document.
www.sec.gov
August 19, 2026 at 9:02 PM
🚨 $LNTH
Dinkelborg Ludger (See Remarks) reported special transactions (Non-P/S).
Dinkelborg Ludger (See Remarks) reported special transactions (Non-P/S).
🚨 $LNTH
Brown Kimberly (Chief Accounting Officer) reported special transactions (Non-P/S).
Brown Kimberly (Chief Accounting Officer) reported special transactions (Non-P/S).
SEC Filing: LNTH
Click to view the official SEC document.
www.sec.gov
August 19, 2026 at 9:02 PM
🚨 $LNTH
Brown Kimberly (Chief Accounting Officer) reported special transactions (Non-P/S).
Brown Kimberly (Chief Accounting Officer) reported special transactions (Non-P/S).
LNTH — HOLD 🟡
Lantheus (LNTH) is rated Hold because strong cash generation and a low-debt balance sheet are offset by uneven quarterly revenue growth. Its 24.1x trailing P/E and 16.9x EV/EBITDA leave less room for disappointment.
lf0.com ↗
Lantheus (LNTH) is rated Hold because strong cash generation and a low-debt balance sheet are offset by uneven quarterly revenue growth. Its 24.1x trailing P/E and 16.9x EV/EBITDA leave less room for disappointment.
lf0.com ↗
August 18, 2026 at 11:29 AM
LNTH — HOLD 🟡
Lantheus (LNTH) is rated Hold because strong cash generation and a low-debt balance sheet are offset by uneven quarterly revenue growth. Its 24.1x trailing P/E and 16.9x EV/EBITDA leave less room for disappointment.
lf0.com ↗
Lantheus (LNTH) is rated Hold because strong cash generation and a low-debt balance sheet are offset by uneven quarterly revenue growth. Its 24.1x trailing P/E and 16.9x EV/EBITDA leave less room for disappointment.
lf0.com ↗
Early👀8-18-26
Spu-34, Naz-345, DJI-47
10-yr 4.74%, JP40Y 4.22%🔥
Crude+.6%, Gold-.6%, Slv-1.65%
BTC-.02%
UP: AKR, AMX, BBWI, DUOL, TRP
DN: AMRC, ANF, ATHM, EYPT, GSAT, KRG,
LNTH, METCB, NCLH, TIGO, YSS
Spu-34, Naz-345, DJI-47
10-yr 4.74%, JP40Y 4.22%🔥
Crude+.6%, Gold-.6%, Slv-1.65%
BTC-.02%
UP: AKR, AMX, BBWI, DUOL, TRP
DN: AMRC, ANF, ATHM, EYPT, GSAT, KRG,
LNTH, METCB, NCLH, TIGO, YSS
August 18, 2026 at 12:09 PM
Early👀8-18-26
Spu-34, Naz-345, DJI-47
10-yr 4.74%, JP40Y 4.22%🔥
Crude+.6%, Gold-.6%, Slv-1.65%
BTC-.02%
UP: AKR, AMX, BBWI, DUOL, TRP
DN: AMRC, ANF, ATHM, EYPT, GSAT, KRG,
LNTH, METCB, NCLH, TIGO, YSS
Spu-34, Naz-345, DJI-47
10-yr 4.74%, JP40Y 4.22%🔥
Crude+.6%, Gold-.6%, Slv-1.65%
BTC-.02%
UP: AKR, AMX, BBWI, DUOL, TRP
DN: AMRC, ANF, ATHM, EYPT, GSAT, KRG,
LNTH, METCB, NCLH, TIGO, YSS
BUY $LNTH (LNTH.O) [FDA] @ 12:00:01Z
August 14, 2026 at 12:00 PM
BUY $LNTH (LNTH.O) [FDA] @ 12:00:01Z